We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Ideagen Plc | LSE:IDEA | London | Ordinary Share | GB00B0CM0C50 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 349.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMIDEA
RNS Number : 5314Y
Ideagen PLC
18 May 2016
18 May 2016
Ideagen PLC
("Ideagen," "the Company" or the "Group")
Pre-Close Trading Update
Ideagen PLC (AIM: IDEA), a leading supplier of Information Management software to highly regulated industries, is pleased to provide an update on trading for the year ended 30 April 2016 ahead of the announcement of its full year results.
The Board is pleased to report that trading for the year was robust and results to 30 April 2016 are expected to be in line with market expectations. The Group delivered strong organic revenue growth of 10 per cent., and a full year contribution from Gael which was acquired in January 2015.
The Group expects to report revenue of approximately GBP21.9 million (FY2015: GBP14.4 million), an increase of 52 per cent. resulting in adjusted EBITDA* of approximately GBP6.3 million (FY2015: GBP4.0 million), an increase of 57 per cent. This represents the Group's seventh consecutive year of revenue and EBITDA* growth. In addition, the Group expects to show a significant increase in adjusted EPS** which continues to be an important financial metric for the Group.
Cash generation remained strong, particularly in the second half of the year, and net cash at 30 April 2016 was GBP6.3 million (31 October 2015: GBP5.4 million), after paying GBP1.7 million of deferred consideration, principally for the Gael acquisition, and GBP0.3 million in dividends. The Group continues to maintain a debt-free balance sheet.
The strong trading results have been driven predominately by healthy demand across the Group's Governance, Risk and Compliance ("GRC") markets, including the manufacturing, life sciences, aviation and rail verticals. The Board is also encouraged by the success of the Group's newly launched SaaS platform, Enlighten, which is allowing the Group to win larger contracts and grow high visibility, subscription-based revenue. As a result, the Board remains confident in the long term growth prospects for the Group.
David Hornsby, Chief Executive, commented: "The Group has once again delivered another year of high quality earnings growth, demonstrating the strength of our business model, the quality of our products and the talent of our employees. The Group has significant contracted work in progress, a growing recurring revenue base and a healthy pipeline of new business, which leaves me optimistic about the continued growth opportunities for the Group."
*Earnings before interest, tax, depreciation, amortisation, share based payments, acquisition costs and exceptional items.
**Adjusted diluted earnings per share
Enquiries:
Ideagen plc 01629 699100 David Hornsby, Chief Executive Graeme Spenceley, Finance Director finnCap Limited 020 7220 0500 Stuart Andrews/James Thompson (Nomad) Stephen Norcross (Corporate Broking) Alma PR Hilary Buchanan +44 (0)7515 805218 Josh Royston +44 (0)7780 901979
About Ideagen Group plc
Ideagen is a UK company quoted on the London Stock Exchange AIM market (Ticker: IDEA.L). Ideagen is a supplier of Information Management software with operations in the UK, the United States and the Middle East. The Company specialises in eGRC (Enterprise Governance, Risk and Compliance) and Healthcare solutions for organisations operating within highly regulated industries. With an excellent portfolio of software products, Ideagen is able to provide complete content lifecycle solutions that enable organisations to meet their Regulatory and Quality Compliance standards, helping them to reduce costs and improve efficiency.
The Group has a customer base of over 2,200 organisations using the Ideagen suite of products, including many blue chip names such as BAE Systems, Emirates, Shell and the European Central Bank as well as 150 hospitals in the UK and US.
This information is provided by RNS
The company news service from the London Stock Exchange
END
TSTDDLFFQEFZBBD
(END) Dow Jones Newswires
May 18, 2016 02:00 ET (06:00 GMT)
1 Year Ideagen Chart |
1 Month Ideagen Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions